The probability of cost-effectiveness

<p>Abstract</p> <p>Background</p> <p>The study of cost-effectiveness comparisons between competing medical interventions has led to a variety of proposals for quantifying cost-effectiveness. The differences between the various approaches can be subtle, and one purpose o...

Full description

Bibliographic Details
Main Authors: Stevens John W, O'Hagan Anthony
Format: Article
Language:English
Published: BMC 2002-03-01
Series:BMC Medical Research Methodology
Online Access:http://www.biomedcentral.com/1471-2288/2/5
_version_ 1828274456114495488
author Stevens John W
O'Hagan Anthony
author_facet Stevens John W
O'Hagan Anthony
author_sort Stevens John W
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>The study of cost-effectiveness comparisons between competing medical interventions has led to a variety of proposals for quantifying cost-effectiveness. The differences between the various approaches can be subtle, and one purpose of this article is to clarify some important distinctions.</p> <p>Discussion</p> <p>We discuss alternative measures in the framework of individual, patient-level, incremental net benefits. In particular we examine the probability of cost-effectiveness for an individual, proposed by Willan.</p> <p>Summary</p> <p>We argue that this is a useful addition to the range of cost-effectiveness measures, but will be of secondary interest to most decision makers. We also demonstrate that Willan's proposed estimate of this probability is logically flawed.</p>
first_indexed 2024-04-13T06:34:49Z
format Article
id doaj.art-84d8284e77fc40e2a28758bc1eb7a31b
institution Directory Open Access Journal
issn 1471-2288
language English
last_indexed 2024-04-13T06:34:49Z
publishDate 2002-03-01
publisher BMC
record_format Article
series BMC Medical Research Methodology
spelling doaj.art-84d8284e77fc40e2a28758bc1eb7a31b2022-12-22T02:57:57ZengBMCBMC Medical Research Methodology1471-22882002-03-0121510.1186/1471-2288-2-5The probability of cost-effectivenessStevens John WO'Hagan Anthony<p>Abstract</p> <p>Background</p> <p>The study of cost-effectiveness comparisons between competing medical interventions has led to a variety of proposals for quantifying cost-effectiveness. The differences between the various approaches can be subtle, and one purpose of this article is to clarify some important distinctions.</p> <p>Discussion</p> <p>We discuss alternative measures in the framework of individual, patient-level, incremental net benefits. In particular we examine the probability of cost-effectiveness for an individual, proposed by Willan.</p> <p>Summary</p> <p>We argue that this is a useful addition to the range of cost-effectiveness measures, but will be of secondary interest to most decision makers. We also demonstrate that Willan's proposed estimate of this probability is logically flawed.</p>http://www.biomedcentral.com/1471-2288/2/5
spellingShingle Stevens John W
O'Hagan Anthony
The probability of cost-effectiveness
BMC Medical Research Methodology
title The probability of cost-effectiveness
title_full The probability of cost-effectiveness
title_fullStr The probability of cost-effectiveness
title_full_unstemmed The probability of cost-effectiveness
title_short The probability of cost-effectiveness
title_sort probability of cost effectiveness
url http://www.biomedcentral.com/1471-2288/2/5
work_keys_str_mv AT stevensjohnw theprobabilityofcosteffectiveness
AT ohagananthony theprobabilityofcosteffectiveness
AT stevensjohnw probabilityofcosteffectiveness
AT ohagananthony probabilityofcosteffectiveness